Skip to main content
Caplight Logo









QCDx

QCDx

Private
Farmington, ConnecticutHealthcare & Life Scienceshttps://www.qcd-x.com/

Last Round

Debt

May 1, 2025

Total Funding Raised

$8.9M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

QCDx is a biotechnology company that develops and provides liquid biopsy technologies and instruments for the detection and proteomic profiling of circulating tumor cells.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical Imaging, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

liquid biopsycirculating tumor cellsCTCcancer diagnosticssingle-cell analysis3D optical tomographyfluorescence microscopycancer research toolsbiotech hardwareAI image analysisprecision oncologydrug discoveryclinical laboratoryCLIA labcancer screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

QCDx Comparables

Compare QCDx with similar companies based on industry and business-model similarity.

QCDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vortex Biosciences
82%
Rarecells
81%
Menarini Group
74%

QCDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMay 1, 2025
SeedMay 1, 2025
Convertible DebtDec 20, 2019
Convertible DebtFeb 6, 2018
Convertible DebtDec 15, 2017

Key People

Founding team and executive leadership

Fyl Tafas

Founder CEO

Founding Team

Triantafyllos Tafas

Founder CEO

Founding Team

QCDx Investors

Notable investors and investment history

QCDx investors
InvestorRounds
Connecticut InnovationsConvertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2026

    Monthly visitors grew 469% MoM, from 71 to 404.

  • May 1, 2025

    $7M debt round completed.

QCDx Filings

Explore SEC and related filing metadata, where available.

QCDx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about QCDx's valuation, stock price, and market status.

Is QCDx a public or private company?

QCDx is a private company.

What is the current stock price of QCDx?

QCDx is a private company, so its shares have no public market price. Caplight tracks QCDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is QCDx worth (valuation)?

Valuation information for QCDx is not publicly available.

Can I buy QCDx stock?

QCDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was QCDx's last funding round?

QCDx's most recent funding round was Debt on May 1, 2025.

Who are the main investors in QCDx?

Key investors in QCDx include Connecticut Innovations.

Will QCDx IPO soon?

No public IPO plans have been announced for QCDx.

How can I track QCDx secondary market activity?

Caplight tracks bids, offers, and trades in QCDx's shares on secondary markets.

Firmographic Details

HeadquartersFarmington, Connecticut
Employee Range16
Year Founded2017
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?